ResMed Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $383.4M | $398.7M | $392.6M | $348.5M | $379.7M | $365.0M | $344.6M | $311.4M |
| Depreciation & Amortization | $44.8M | $59.0M | $49.9M | $47.7M | $63.6M | $43.7M | $46.4M | $44.7M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $8.3M | $7.9M | $7.8M | $7.8M | $9.4M | $7.4M | $7.6M | $7.7M |
| Stock-Based Compensation | $27.5M | $26.8M | $28.9M | $21.2M | $24.8M | $24.1M | $22.6M | $20.2M |
| Net Cash from Operating Activities | $454.6M | $554.1M | $339.7M | $457.3M | $538.8M | $578.7M | $308.6M | $325.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $51.1M | $33.7M | $28.5M | $43.0M | $30.6M | $20.8M | $20.6M | $17.8M |
| Business Acquisitions | $325.3M | $24.9M | $0 | $522.0K | $138.6M | $0 | $670.0K | $0 |
| Net Cash from Investing Activities | $-383.7M | $-58.0M | $-50.9M | $-52.6M | $-133.7M | $-31.8M | $-36.7M | $2.1M |
| Financing Activities | ||||||||
| Dividends Paid | $87.1M | $87.2M | $87.6M | $87.8M | $77.6M | $77.7M | $77.7M | $77.9M |
| Stock Repurchases | $200.0M | $175.0M | $175.0M | $150.0M | $100.0M | $75.0M | $75.0M | $50.0M |
| Net Cash from Financing Activities | $-263.2M | $-255.2M | $-258.3M | $-230.3M | $-163.9M | $-144.1M | $-147.5M | $-150.8M |
| Net Change in Cash | $-191.3M | $243.4M | $33.2M | $174.4M | $276.7M | $410.8M | $95.6M | $188.0M |
| Free Cash Flow | $403.5M | $520.5M | $311.2M | $414.4M | $508.2M | $557.9M | $288.0M | $307.7M |